1.72 USD
+0.14 (+8.86%)
1.66 USD
-0.06 (-3.49%)
ChartMill assigns a Buy % Consensus number of 83% to ESLA. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 16.32. This target is 848.84% above the current price.
ESLA was analyzed by 7 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about ESLA.
In the previous month the buy percentage consensus was at a similar level.
ESLA was analyzed by 7 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-11-03 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-08-12 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-06-03 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-05-29 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-02-21 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-02-18 | D. Boral Capital | Initiate | Buy |
ESTRELLA IMMUNOPHARMA INC / ESLA FAQ
What is the average price target for ESTRELLA IMMUNOPHARMA INC (ESLA) stock?
7 analysts have analysed ESLA and the average price target is 16.32 USD. This implies a price increase of 848.84% is expected in the next year compared to the current price of 1.72.
What is the consensus rating for ESLA stock?
The consensus rating for ESTRELLA IMMUNOPHARMA INC (ESLA) is 82.8571 / 100 . This indicates that analysts generally have a positive outlook on the stock.